HomeCompareQGPLF vs MRK

QGPLF vs MRK: Dividend Comparison 2026

QGPLF yields 22.20% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QGPLF wins by $26.7K in total portfolio value
10 years
QGPLF
QGPLF
● Live price
22.20%
Share price
$9.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$83.5K
Annual income
$8,464.93
Full QGPLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — QGPLF vs MRK

📍 QGPLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQGPLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QGPLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QGPLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QGPLF
Annual income on $10K today (after 15% tax)
$1,886.79/yr
After 10yr DRIP, annual income (after tax)
$7,195.19/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $1,133.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QGPLF + MRK for your $10,000?

QGPLF: 50%MRK: 50%
100% MRK50/50100% QGPLF
Portfolio after 10yr
$70.1K
Annual income
$9,131.54/yr
Blended yield
13.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

QGPLF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QGPLF buys
0
MRK buys
0
No recent congressional trades found for QGPLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQGPLFMRK
Forward yield22.20%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$83.5K$56.8K
Annual income after 10y$8,464.93$9,798.13
Total dividends collected$50.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QGPLF vs MRK ($10,000, DRIP)

YearQGPLF PortfolioQGPLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,920$2,219.76$11,206$366.19+$1.7KQGPLF
2$16,504$2,680.25$12,650$502.35+$3.9KQGPLF
3$20,860$3,199.91$14,407$694.19+$6.5KQGPLF
4$26,099$3,779.72$16,585$967.82+$9.5KQGPLF
5$32,346$4,419.80$19,342$1,363.89+$13.0KQGPLF
6$39,730$5,119.30$22,913$1,947.19+$16.8KQGPLF
7$48,387$5,876.50$27,662$2,823.89+$20.7KQGPLF
8$58,463$6,688.84$34,159$4,173.35+$24.3KQGPLF
9$70,109$7,552.99$43,337$6,308.80+$26.8KQGPLF
10$83,481$8,464.93$56,776$9,798.13+$26.7KQGPLF

QGPLF vs MRK: Complete Analysis 2026

QGPLFStock

Quest for Growth Belgium is a mutual fund launched and managed by Quest Management NV. The fund makes its investments in listed and unlisted companies of Europe. It primarily invests in growth stocks of smaller capitalization companies and small and medium sized companies. The fund also invests in venture funds, and unquoted technology companies. It employs bottom-up stock picking approach along with fundamental analysis to make its investments. The fund invests in companies in software and services, technology hardware, semiconductors, health care equipment and services, pharma and biotech, electrical and engineering, and materials sectors. It was established in 1998 and is based in Leuven, Belgium.

Full QGPLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this QGPLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QGPLF vs SCHDQGPLF vs JEPIQGPLF vs OQGPLF vs KOQGPLF vs MAINQGPLF vs JNJQGPLF vs ABBVQGPLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.